33rd Scoliosis Research Society (SRS)

International Meeting on Advanced Spine Techniques (IMAST)

Toronto, ON, Canada
April 15-18, 2026

Abstract Submission: July 1, 2025 - October 1, 2025

IMPORTANT DATES

• Abstract Submission Dates: July 1 - October 1, 2025, 11:59 PM EDT (US)
• Abstract Acceptance Notification via email: December 10, 2025*
• Abstract Presenter Acceptance Deadline: January 6, 2026*
• Meeting Dates: April 15-18, 2026

*Dates are subject to change.

SRS MEMBERSHIP

Abstracts can be submitted by SRS Members and non-members.

MEETING THEME

The Future of Spine: Driving Innovation & Cultivating Leadership

ABSTRACT CATEGORIES

Abstract submission to IMAST must fit into one of the following categories to be considered for presentation.

• Adolescent Idiopathic Scoliosis (Non-op, Fusion and VBT)
• Adult Spinal Deformity
• AI & Machine Learning*
• Basic Science / Biomechanics / Genetics
• Cervical Spine: Deformity & Degenerative
• Early Onset, Neuromuscular, Congenital Scoliosis & Scheuermann's
• Emerging and Enabling Technologies (Navigation, Robotics, AR, Optical Nav., Haptic, Endoscopy)
• Infection, Trauma, Tumor
• Innovations in Education, Training & Simulation
• Lumbar Diseases (including Spondylolisthesis)
• Minimally Invasive Approaches (Lateral access surgery, Endoscopic, Outpatient Surgery)
• Quality / Safety / Value / Complications

*AI & Machine Learning: Abstracts eligible for this category will describe utilization of artificial intelligence, machine learning, predictive analytics, or wearable technology in the diagnosis, treatment planning, intraoperative guidance, or postoperative care of operative spine pathology.

Authors can choose optional sub-categories to further classify their topic. More than one sub-category can be selected:

Sub-Categories
Minimally Invasive	Novel Technique
Motion Preservation	Complications

ABSTRACT SUBMISSION INSTRUCTIONS

• Abstracts are limited to a maximum of 2,500 characters
  • Characters in the abstract title, body and table/image caption will be counted (including spaces)
  • Characters in the author and institution listing will not be counted
• For each co-author listed, you will need:
  • Full name
  • Designation/degree
  • Email (please ensure to double check all email addresses entered)
  • Country
  • Institution/affiliation
• Limit of one graph, figure or table, max, for each submitted abstract.
• Submitters may revisit the site as often as necessary to edit the submission (finalized or not) at any time before the submission deadline.
• No changes can be made to the abstract text after the submission deadline.

Full directions for abstract submission can be found here.

Please note: In order to successfully receive emails regarding your submission, you must add '@owpm2.com' as a safe sender in your email client. Click here for help adding safe senders.

PREVIOUS PUBLICATION

Abstracts which have been published online or in print in a journal at the time of submission are NOT eligible for submission.

ONE-YEAR FOLLOW-UP REQUIREMENT

One-year clinical follow-up is required for abstract submission. The one-year follow up rule does not apply to categories of basic science or biomechanical studies or for topics where one-year follow up is irrelevant such as 30-day re-admission rates.

DISCLOSURE AND LICENSING REQUIREMENT

ALL authors listed on an abstract will be required to submit a Financial Relationship Disclosure form which must include ALL financial relationships held in the past 24 months with ineligible companies*, regardless of their relevancy to the topic of the abstract(s).

If authors on an abstract have not completed these required forms prior to the submission deadline, the abstract will NOT be reviewed or considered for the meeting program.

*An ineligible company is an entity whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services consumed by or on patients. For specific examples of ineligible companies visit accme.org/standards.

SRS PRODUCT-SPECIFIC LANGUAGE POLICY

SRS strongly prefers that pharmaceuticals and proprietary software/databases as well as surgical approaches or specific instrumentation such as "Surgimap, MIMICS, EOS Imaging, ROTEM, XLIF, DLIF, AxiaLIF, Solera, Vertex, Expedium, Mountaineer, Shilla, VEPTR, etc.," are not used in presentations. These terms should be replaced by a generic term or description of the drug, software/database and/or instrumentation or technique unless the use of the term directly impacts learners' understanding of the presentation or data. Instrumentation may also be referred to when the device name is a landmark system that is no longer sold (i.e. Harrington, Cotrel-Dubousset, Luque). It is recognized that studies evaluating a device or devices or comparing different devices or techniques may require the use of product or technique names. If a device trade name or industry developed technique using a trademarked name are used in an abstract or presentation, it will be specifically reviewed by the CME Committee for evaluation of any relevant financial relationships. When there is a known financial relationship, expanded verbal disclosure will be necessary at the time of presentation. Furthermore, if a product name is mentioned, the audience should be informed of why it is necessary to give the name.

Please review the SRS Product Translation Glossary for more information.

ATTENDANCE REQUIREMENTS

• By submitting an abstract to IMAST, abstract authors agree that at least one (1) author will attend the meeting and will be available to present on the date and time assigned.
• In addition, presenting authors are expected to register to attend the meetings for which they are accepted by the deadline set forth in their acceptance notification. Abstracts for which an author is not pre-registered by the dates set forth may be withdrawn from the program.
• All travel arrangements are the responsibility of the authors.

ACCEPTANCE

• All selected authors will be required to respond to a formal invitation by the deadline set forth in their acceptance notification.
• Authors without an account AND an updated disclosure cannot be added after the invitation response deadline. No exceptions will be made.

PODIUM PRESENTATION CANCELLATION & NO-SHOW POLICY

Authors unable to present their paper in-person should inform SRS as soon as possible with a co-author that can attend to present the paper. If no one is able to attend in-person, please inform the SRS Education Team by the date set forth in your acceptance notification, so an alternate paper can be substituted.

Please note: In the case of a "no-show" podium presentation, the presenting author associated with the "no-show" paper will be prohibited from presenting any papers at the next two IMAST meetings.

E-POINT PRESENTATION CANCELLATION POLICY

At least one author or co-author on all E-Point presentations is expected to register to attend the meeting by the deadline set forth in their acceptance notification.

If this author cancels their registration prior to the meeting, the E-Point presentation may be withdrawn from the program.

CME REVIEW

All presentations must clear a CME review conducted by the SRS CME Committee. Presenters may be required to submit slides for review before the meeting and may be asked to make small or significant changes if a bias issue is found.

Failure to address pertinent CME review issues will result in pulling the presentation from the program and in a one-year ban for abstract presentations and a three-year ban for invited presentations.

NOTIFICATIONS

All submitters will be notified via email of the status of their submission(s) on December 10, 2025. In the event that you do not receive any notification, please log into the submission site at ANY time to view any recent mail regarding your submissions.

TECHNOLOGY TROUBLESHOOTING

• Please ensure you are using one of the following browsers: Mozilla Firefox 4+, Safari 5+, Chrome 14+, Microsoft Edge.
• Browser back and forward arrows have been disabled. Users must use the page progress bar located at the top left of each page.
• Inactivity of more than 90 minutes on system pages will result in a session time out. Please save your pages intermittently to avoid loss of data.
• For technical assistance, please email education@srs.org. Support requests are answered within 1 business day.
• In order to successfully receive emails regarding your submission, you must add '@owpm2.com' as a safe sender in your email client. Click here for help adding safe senders.